Literature DB >> 19414283

Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.

Alexander A Zoerner1, Frank M Gutzki, Maria T Suchy, Bibiana Beckmann, Stefan Engeli, Jens Jordan, Dimitrios Tsikas.   

Abstract

Anandamide (arachidonoyl ethanol amide, AEA) is an endocannabinoid, acting on CB1 and CB2 receptors. Elevated plasma AEA concentrations in humans have been associated amongst others with obesity, psychological disorders and miscarriage. The occurrence in human plasma of ethanol amides of other unsaturated and saturated fatty acids, including oleic acid and palmitic acid, has also been reported. Most data available on anandamide and other fatty acid ethanol amides (FAEA) until now have been generated by using the LC-MS/MS methodology. Here, we describe a stable-isotope dilution GC-MS/MS method for the quantitative determination of AEA, oleic acid ethanol amide (OEA) and palmitic acid ethanol amide (PEA) in human plasma using their stable-isotope labeled analogs as internal standards. Other FAEA were found in plasma and their concentration was estimated. The present method involves a single solvent extraction of FAEA and their internal standards from plasma (50-1000 microl) with toluene, derivatization to the pentafluorobenzamide pentafluoropropionyl derivatives (FAEA-PFBz-PFP), and simultaneous quantification by selected reaction monitoring of the carboxylate anions produced by collision-induced dissociation of the parent ions [M-PFBz](-). The present method was fully validated for anandamide. Thus, accuracy and imprecision of the method were within the range of 100+/-20% and less than 20%, respectively, in the range investigated (0-4 nM). Mean overall recovery was 90+/-3%. The LOQ and LOD values of the method were determined to be 0.25 nM of added AEA in plasma samples and 400 amol of injected AEA-PFBz-PFP derivative, respectively. In plasma of 16 healthy individuals AEA concentration was measured to be 1.35+/-0.32 nM. This finding is concordant to literature AEA plasma concentrations as measured by LC-MS/MS. The plasma concentrations of OEA, PEA and other FAEA are higher than that of AEA. This GC-MS/MS method is straightforward, accurate, precise, highly specific for FAEA and useful in basic and clinical research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414283     DOI: 10.1016/j.jchromb.2009.04.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  10 in total

Review 1.  Mass spectrometry strategies in metabolomics.

Authors:  Zhentian Lei; David V Huhman; Lloyd W Sumner
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Pitfalls in the sample preparation and analysis of N-acylethanolamines.

Authors:  Christian Skonberg; Andreas Artmann; Claus Cornett; Steen Honoré Hansen; Harald S Hansen
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

3.  Changes of blood endocannabinoids during anaesthesia: a special case for fatty acid amide hydrolase inhibition by propofol?

Authors:  Carina Jarzimski; Matthias Karst; Alexander A Zoerner; Christin Rakers; Marcus May; Maria T Suchy; Dimitrios Tsikas; Joachim K Krauss; Dirk Scheinichen; Jens Jordan; Stefan Engeli
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

4.  In vivo monitoring of rat brain endocannabinoids using solid-phase microextraction.

Authors:  Momna Aslam; Carlos Feleder; Ryan J Newsom; Serge Campeau; Florin Marcel Musteata
Journal:  Bioanalysis       Date:  2019-09-05       Impact factor: 2.681

5.  Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs.

Authors:  Antoni Pastor; Magí Farré; Montserrat Fitó; Fernando Fernandez-Aranda; Rafael de la Torre
Journal:  J Lipid Res       Date:  2014-03-07       Impact factor: 5.922

6.  Exercise-induced endocannabinoid signaling is modulated by intensity.

Authors:  David A Raichlen; Adam D Foster; Alexandre Seillier; Andrea Giuffrida; Gregory L Gerdeman
Journal:  Eur J Appl Physiol       Date:  2012-09-19       Impact factor: 3.078

7.  Endocannabinoids as potential biomarkers: It's all about pre-analytics.

Authors:  Daniel Kratz; Dominique Thomas; Robert Gurke
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-11-10

8.  Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls.

Authors:  Christian Lanz; Johan Mattsson; Felix Stickel; Jean-Francois Dufour; Rudolf Brenneisen
Journal:  Med Cannabis Cannabinoids       Date:  2018-06-12

9.  The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

Authors:  Christopher P Stanley; William H Hind; Christina Tufarelli; Saoirse E O'Sullivan
Journal:  Pharmacol Res       Date:  2016-09-12       Impact factor: 7.658

Review 10.  Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification.

Authors:  Jantana Keereetaweep; Kent D Chapman
Journal:  Neural Plast       Date:  2015-12-29       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.